Carol Burke, MD

216.444.7000

Carol Burke, MD
Department: Gastroenterology and Hepatology
Location: Cleveland Clinic Main Campus
Mail Code A30
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.7000
DeskDesk:216.444.6864
WorkFax:216.444.6305
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Carol Burke, MD, completed medical school at the Ohio State University College of Medicine and Public Health, and residency at Riverside Methodist Hospital, both in Columbus, Ohio. Dr. Burke performed her Gastroenterology Fellowship at the Cleveland Clinic in 1993 and has been on the professional staff since that time.

Dr. Burke enjoys patient care, medical education and research, particularly in the area of colorectal polyp and cancer prevention. She is internationally known for her work in the polyposis syndromes and is the Director of the Center for colon polyp and cancer prevention and has been awarded research grants from the National Cancer Institute, American College of Gastroenterology, and Industry to name a few,  to study the effects of chemopreventive agents on the prevention of intestinal neoplasia.

She is the co-director of the multi-disciplinary Hereditary Cancer Clinic and provides consultations including risk assessment, and endoscopic evaluation and treatment for individuals with a hereditary predisposition to cancer.

She is the author of numerous peer reviewed manuscripts, abstracts, book chapters, and is a frequent reviewer for many digestive disease journals.

She has served as a committee member, or chairperson in the American College of Gastroenterology, American Society of Gastrointestinal Endoscopy and is currently on the Board of Trustees for the American College of Gastroenterology.

Professional Highlights

  • Associate Editor for the American Journal of Gastroenterology
  • Reviewer for the journals: Gastroenterology, Clinical Gastroenterology and Hepatology, Diseases of the Colon and Rectum, Gastrointestinal Endoscopy, Archives of Internal Medicine

Education & Fellowships

Fellowship - Cleveland Clinic
Gastroenterology
Cleveland, OH USA
1993
Residency - Riverside Methodist Hospital
Internal Medicine
Columbus, OH USA
1991
Internship - Riverside Methodist Hospital
Internal Medicine
Columbus, OH USA
1989
Medical School - The Ohio State University College of Medicine and Public Health
Columbus, OH USA
1988
Undergraduate - University of Colorado
Exercise Physiology
Boulder, CO USA
1980

Certifications

  • Internal Medicine- Gastroenterology
  • Internal Medicine

Specialty Interests

chemoprevention of colorectal neoplasia, colonic neoplasia, colorectal cancer screening strategies, hereditary polyposis and nonpolyposis colorectal cancer, Colon cancer prevention, colon cancer screening, Colonoscopy

Awards & Honors

Dr. Burke is on the Board of Trustees of the American College of Gastroenterology.

Dr. Burke is a member of the National Medical Honor Society, Alpha Omega Alpha

Memberships

  • Fellow, American College of Gastroenterology
  • Fellow, American College of Physicians
  • Member, American Society of Gastrointestinal Endoscopy
  • Member, American Gastroenterologic Association
  • Member, International Society on Inherited Gastrointestinal Hereditary Tumors

Treatment & Services

  • Chemoprevention
  • Colonoscopy
  • Colorectal Cancer Screening Strategies
  • Endoscopy
  • Flexible Sigmoidoscopy
  • Ileoscopy
  • Inherited Colon Cancer Risk Assessment
  • Polypectomy
  • Pouchoscopy
  • Push Enteroscopy
  • Wireless Capsule Endoscopy

Specialty in Diseases and Conditions

  • Colon Polyps
  • Colonic Neoplasia
  • Colorectal Cancer
  • Duodenal Polyps
  • Familial Adenomatous Polyposis
  • Fundic Gland Polyps
  • Hereditary Non Polyposis Colorectal Cancer
  • Juvenile Polyposis
  • Peutz- Jeghers Syndrome
  • Polyposis Syndromes

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 12/1/2013, Dr. Burke has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Burke received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Ferring Pharmaceuticals, Inc.
  • Takeda Global Research & Development Center, Inc.

Donation of Financial Interest. Dr. Burke has consulted for, received compensation for serving as a fiduciary from, or received royalties from the following companies but instructed them to donate all compensation:

  • Pfizer, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site